Metastatic disease in conjunctival malignant melanoma: a retrospective analysis of 167 cases
In conjunctival melanoma, it is important to perform an adjuvant therapy after excision. This reduces not only local recurrences but also significantly the risk for haematopoietic spread.
Authors
- Anke Manthey
- J. Hérault (ORCID: https://orcid.org/0000-0003-4155-6155)
- Ahmad Rahal (ORCID: https://orcid.org/0000-0002-3437-3193)
- Maja Guberina (ORCID: https://orcid.org/0000-0003-3218-0539)
- Martin Stuschke (ORCID: https://orcid.org/0000-0001-6836-0940)
- Dirk Flühs
- Daniela Suesskind
- Henrike Westekemper (ORCID: https://orcid.org/0000-0001-7389-9692)
- W. Sauerwein
- NE Bechrakis
- Klaus Griewank
- Melisa Sezgin
- Dirk Schadendorf
- Veronika Nowack
Institutions
- Essen University Hospital (DE)
- University Children's Hospital Tübingen (DE)
- Centre Antoine Lacassagne (FR)
Publication Details
- Journal
- BMJ Open Ophthalmology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1136/bmjophth-2025-002172
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00